REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/02/2026
Back to search
Official data from USPTO
ZIONEXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079291398Class
5, 10, 41, 42, 44
Filing
79291398
Registration
6279657
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/03/2026
Trademark type
Combined
Nice classes
5, 10, 41, 42, 44
Filing date
06/29/2020
Registration date
03/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2021
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
GB
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the blue wording "ZIONEXA". The middle horizontal line of "E" is red. A red arrow appears on the left side of the "X". The white background is not a feature of the mark.
Holders and representatives
Holders
GE Healthcare Limited
ZIONEXA
Representatives
Marina Dostal GE Precision Healthcare LLC
Technical classification
Nice Classes
Class 5Class 10Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Radiopharmaceuticals for treating oncological diseases; in-vivo diagnostic markers used for detection and monitoring of oncological therapy; pharmaceutical preparations for human and veterinary use for treating oncological diseases; biological preparations for medical use for treating cancer; chemical preparations for medical use for treating cancer; food supplements and nutritional supplements for medical use; dietetic food and beverages for medical and pharmaceutical use; homeopathic supplements; plant therapy compositionsmedicinal teas; sanitary tampons for medical purposes; medicated bath preparations; dietetic beverages for medical use; chemical diagnostic reagents for medical usebiomarkers; products for personal hygiene for medical purposesmedicated douching preparations; medical plasters; medical dressings; surgical and medical dressings
Class 10
Medical devices for diagnostic use for administering contrast media; medical diagnostic instruments for detecting cancer; surgical apparatus and instruments; medical instruments for collection of human body fluids; kits primarily comprised of surgical instruments; containers for medical cancer samples; medicine administering tubes for surgical applications; container holders specifically adapted for holding medical samples; medicine administering tubes for medical applications; syringes for medical use; syringe needles for medical use; containers especially adapted for depositing medical syringes
Class 41
Training services in the fields of healthcarepharmaceuticalsmedical researchpharmaceuticalmedicine development; publication of books and texts other than advertising texts in the pharmaceuticalmedical and health fields; arranging and conducting of colloquiumsconferencescongressesseminars in the pharmaceuticalmedical and health fields
Class 42
Development of pharmaceutical products; pharmaceutical research and development; testing in the form of quality control for others of pharmaceutical products; carrying out clinical trials for pharmaceutical products for others; scientific research regarding medicine; computer bio-informatic systemchemical and biological analysis; research in chemistrycosmetologybiologybacteriologynutritionbiotechnology; biological and bio-informatic research services in the field of chemicalbiological and pharmaceutical products; software design and development in the field of pharmaceuticalhealth and medical research; Providing medical and scientific research information in the field of pharmaceutical products and clinical trials; research on chemical reagents for medical usebiomarkers; design of databases in the field of pharmaceutical research and developmentmedicinegenetics and clinical trials
Class 44
Dispensing of pharmaceuticals services; pharmaceutical advice; medical services; medical information services; providing medical information; information services on the treatment of diseases via an awareness program; providing information with respect to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
36 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/23/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/31/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/24/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/11/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/30/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/30/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/30/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/30/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/30/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/30/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/28/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2021
FIMP
FINAL DISPOSITION PROCESSED
06/03/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/15/2020
PUBO
PUBLISHED FOR OPPOSITION
12/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/25/2020
RFNT
REFUSAL PROCESSED BY IB
11/14/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/24/2020
RFRR
REFUSAL PROCESSED BY MPU
10/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/03/2020
CNRT
NON-FINAL ACTION WRITTEN
10/02/2020
DOCK
ASSIGNED TO EXAMINER
10/01/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/13/2020
Continuous trademark protection
Get notified about every new filing that threatens ZIONEXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.